UW6-25124-35809
2 vaccinations
2 coded responses
11 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 201 / VA
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- 337-30162-35182
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Dose 1 — Moderna
-
2022-06-27
Registered in v-safe
-
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-07-03
-
2022-07-15
Survey response — day 21, dose 1, under 3MedDRA: Respiratory syncytial virus infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: RSV.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-15
Report sent to call center — day 21, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-07-18
- 2022-07-21
- 2022-07-24
-
2022-07-30
Dose 2 — Moderna
- 2022-08-03
- 2022-08-04
- 2022-08-05
- 2022-08-06
- 2022-08-19
-
2022-10-29
Survey response — 3 months, dose 2, under 3MedDRA: Hand-foot-and-mouth disease — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hand foot and mouth diseaseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-01
- 2022-11-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Moderna | No |
| 2 | 2022-07-30 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-15 | Unsuccessful | |
| 2022-10-29 | Unsuccessful |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: RSV.
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Hand foot and mouth disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release